Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001104659-20-056066)

Filing Details

Accession Number:
0001104659-20-056066
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-04 12:28:21
Reporting Period:
2020-04-30
Accepted Time:
2020-05-04 12:28:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1173281 Neubase Therapeutics Inc. NBSE Pharmaceutical Preparations (2834) 465622433
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579887 Samuel Backenroth C/O 700 Technology Drive, Third Floor
Pittsburgh PA 15219		 Cfo, Treasurer & Secretary No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-04-30 1,000 $6.00 11,630 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The power of attorney under which this form was signed is on file with the Commission.